Enhancing Comprehensive Assessments in Chronic Heart Failure Caused by Ischemic Heart Disease: The Diagnostic Utility of Holter ECG Parameters

被引:1
|
作者
Duca, Stefania-Teodora [1 ,2 ]
Tudorancea, Ionut [2 ,3 ]
Haba, Mihai Stefan Cristian [1 ,2 ]
Costache, Alexandru-Dan [1 ,4 ]
Serban, Ionela-Lacramioara [3 ]
Paval, D. Robert [5 ]
Loghin, Catalin [6 ]
Costache-Enache, Irina-Iuliana [1 ,2 ]
机构
[1] Univ Med & Pharm Grigore T Popa, Fac Med, Dept Internal Med 1, Iasi 700115, Romania
[2] St Spiridon Emergency Cty Hosp, Dept Cardiol, Iasi 700111, Romania
[3] Univ Med & Pharm Grigore T Popa, Dept Morpho Funct Sci Physiol 2, Iasi 700115, Romania
[4] Clin Rehabil Hosp, Dept Cardiovasc Rehabil, Iasi 700661, Romania
[5] Univ Stirling, Fac Hlth Sci & Sport, Stirling FK9 4LA, Scotland
[6] Univ Texas, Dept Internal Med, Cardiol Div, Hlth Sci Ctr, Houston, TX 77030 USA
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 08期
关键词
ischemic heart disease; chronic heart failure; 24 h Holter ECG; SUDDEN CARDIAC DEATH; T-WAVE ALTERNANS; CORONARY-ARTERY-DISEASE; RATE-VARIABILITY; 24-HOUR HOLTER; DECELERATION CAPACITY; RATE TURBULENCE; RISK; ELECTROCARDIOGRAM; MORTALITY;
D O I
10.3390/medicina60081315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Chronic heart failure (CHF) caused by ischemic heart disease (IHD) is the leading cause of death worldwide and presents significant health challenges. Effective management of IHD requires prevention, early detection, and treatment to improve patient outcomes. This study aims to expand the diagnostic utility of various 24 h Holter ECG parameters, such as T-wave alternans (TWA), late ventricular potentials (LVPs), and heart rate variability (HRV) in patients with CHF caused by IHD. Additionally, we seek to explore the association between these parameters and other comorbid conditions affecting the prognosis of CHF patients. Materials and Methods: We conducted a prospective case-control study with 150 patients divided into two subgroups: 100 patients with CHF caused by IHD, and 50 patients in the control group. Data included medical history, physical examination, laboratory tests, echocardiography, and 24 h Holter monitoring. Results: Our comparative analysis demonstrated that both TWA and LVPs were significantly higher in patients with CHF compared to the control group (p < 0.01), indicating increased myocardial electrical vulnerability in CHF patients. Both time and frequency-domain HRV parameters were significantly lower in the CHF group. However, the ratio of NN50 to the total count of NN intervals (PNN50) showed a borderline significance (p = 0.06). While the low-frequency (LF) domain was significantly lower in CHF patients, the high-frequency (HF) domain did not differ significantly between groups. Acceleration and deceleration capacities were also significantly altered in CHF patients. Categorizing CHF patients by left ventricular ejection fraction (LVEF) revealed that the mean of the 5-min normal-to-normal intervals over the complete recording (SDNN Index) was significantly higher in patients with LVEF >= 50% compared to those with CHF with reduced EF and CHF with mildly reduced EF (p < 0.001), whereas the other HRV parameters showed no significant differences among the groups. Conclusions: Holter ECG parameters can become a reliable tool in the assessment of patients with CHF. The integration of multiple Holter ECG parameters, such as TWA, LVPs, and HRV, can significantly enhance the diagnostic assessment of CHF caused by IHD. This comprehensive approach allows for a more nuanced understanding of the patient's condition and potential outcomes.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Pulmonary hypertension due to left heart disease: diagnostic and prognostic value of CT in chronic systolic heart failure
    Geoffrey C. Colin
    Bernhard L. Gerber
    Christophe de Meester de Ravenstein
    David Byl
    Anna Dietz
    Michele Kamga
    Agnes Pasquet
    David Vancraeynest
    Jean-Louis Vanoverschelde
    Anne-Marie D’Hondt
    Benoit Ghaye
    Anne-Catherine Pouleur
    European Radiology, 2018, 28 : 4643 - 4653
  • [22] PROGNOSTIC IMPORTANCE OF MYOCARDIAL REMODELING PARAMETERS IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE AND ISCHEMIC CARDIOMYOPATHY
    Sisakian, H. S.
    Sanosyan, A. A.
    Sahakyan, L. G.
    Sargsyan, T. M.
    NEW ARMENIAN MEDICAL JOURNAL, 2015, 9 (01): : 27 - 30
  • [23] Comparison of efficacy and safety of ramipril, molsidomine and their combination in patients with chronic heart failure, which complicated ischemic heart disease
    Sinitsina, I. I.
    Orlov, V. A.
    Zaharova, G. J.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2008, 4 (05) : 28 - 33
  • [24] Effect of furosemide and torasemide on heart rate variability and ventricular rhythm disorders in patients with chronic heart failure complicating ischemic heart disease: comparative nonrandomized study
    Shugushev, H. H.
    Gaeva, A. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2010, 6 (04) : 513 - 517
  • [25] Endothelial dysfunction in patients with ischemic heart disease complicated by chronic heart failure and possibilities of its correction with isosorbide-5-mononitrate
    Olbinskaya, LI
    Sizova, ZM
    Ushakova, AV
    KARDIOLOGIYA, 2001, 41 (03) : 29 - 32
  • [26] Comparison of Detection of Arrhythmias in Patients With Chronic Heart Failure Secondary to Non-Ischemic Versus Ischemic Cardiomyopathy by 1 Versus 7-Day Holter Monitoring
    Pastor-Perez, Francisco J.
    Manzano-Fernandez, Sergio
    Goya-Esteban, Rebeca
    Pascual-Figal, Domingo A.
    Barquero-Perez, Oscar
    Luis Rojo-Alvarez, Jose
    Martinez Martinez-Espejo, Maria Dolores
    Valdes Chavarri, Mariano
    Garcia-Alberola, Arcadio
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (05) : 677 - 681
  • [27] Holter Monitoring (24-Hour ECG) Parameter Dynamics in Patients with Ischemic Heart Disease and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
    Fiev, Dmitrii N.
    Vinarov, Andrey Z.
    Tsarichenko, Dmitrii G.
    Kopylov, Phillip Yu.
    Demidko, Yuri L.
    Syrkin, Abram L.
    Rapoport, Leonid M.
    Alyaev, Yuri G.
    Glybochko, Pyotr V.
    ADVANCES IN THERAPY, 2019, 36 (08) : 2072 - 2085
  • [28] Benefits of a comprehensive care model in patients with heart failure and chronic obstructive pulmonary disease: UMIPIC program
    Bailon, M. Mendez
    Gonzalez-Franco, A.
    Cerqueiro, J. M.
    Perez-Silvestre, J.
    Garcia, C. Moreno
    Conde-Martel, A.
    Arevalo-Lorido, J. C.
    Perez, F. Formiga
    Manzano-Espinosa, L.
    Montero-Perez-Barquero, M.
    REVISTA CLINICA ESPANOLA, 2025, 225 (01): : 1 - 8
  • [29] The association of ghrelin polymorphisms with coronary artery disease and ischemic chronic heart failure in an elderly Chinese population
    Zhang, Qin
    Huang, Wei-dong
    Lv, Xue-ying
    Yang, Yun-mei
    CLINICAL BIOCHEMISTRY, 2011, 44 (5-6) : 386 - 390
  • [30] Clinico-diagnostic significance of cytokine activation and changes of morphofunctional parameters of the heart in patients with chronic heart failure and possibilities of correction of revealed disturbances with simvastatin
    Rebrov, A. P.
    Tolstov, S. N.
    KARDIOLOGIYA, 2007, 47 (05) : 14 - 18